Literature DB >> 7650257

The use of propofol for sedation of critically ill patients undergoing haemodiafiltration.

J M Eddleston1, B J Pollard, J F Blades, B Doran.   

Abstract

OBJECTIVE: To assess the requirement for propofol to provide sedation in critically ill patients in established renal failure during the commencement of haemodiafiltration.
DESIGN: Prospective clinical study.
SETTING: ICU, University Hospital. PATIENTS: 10 adult patients. All were mechanically ventilated, had acute oliguric renal failure which necessitated continuous veno-venous haemodiafiltration and were receiving a continuous intravenous infusion of propofol for sedation. Sedation was assessed using a scoring system. INTERVENTION: Veno-venous haemodiafiltration. MEASUREMENTS AND
RESULTS: Connection of the extracorporeal circuit produced a reduction in plasma propofol concentration in 7 out of 9 patients (one sample misplaced) with subsequent awakening in 3 of these 7 patients. The commencement of haemodiafiltration itself did not significantly influence the requirement for propofol (8 out of 10 patients).
CONCLUSION: Haemodiafiltration does not substantially influence the requirement for propofol but the initial introduction of the extracorporeal circuit will reduce plasma concentrations in the majority of patients. This may be due to haemodilution alone or absorption of plasma albumin (with propofol) onto the membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650257     DOI: 10.1007/bf01705413

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  [Continuous flow propofol during kidney transplantation in the adult].

Authors:  V Reiter; R Fay; J C Pire; D Lamiable; J Rendoing
Journal:  Cah Anesthesiol       Date:  1989 Jan-Feb

2.  Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients.

Authors:  G R Bailie; I D Cockshott; E J Douglas; B J Bowles
Journal:  Br J Anaesth       Date:  1992-05       Impact factor: 9.166

3.  Propofol infusion for sedation of patients with head injury in intensive care. A preliminary report.

Authors:  P A Farling; J R Johnston; D L Coppel
Journal:  Anaesthesia       Date:  1989-03       Impact factor: 6.955

4.  Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection.

Authors:  G F Plummer
Journal:  J Chromatogr       Date:  1987-10-09

Review 5.  Pathogenesis and management of lipoprotein disorders.

Authors:  E J Schaefer; R I Levy
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

6.  Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients.

Authors:  J Albanese; C Martin; B Lacarelle; P Saux; A Durand; F Gouin
Journal:  Anesthesiology       Date:  1990-08       Impact factor: 7.892

7.  Propofol infusion for sedation in the intensive care unit: preliminary report.

Authors:  R M Grounds; J M Lalor; J Lumley; D Royston; M Morgan
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

8.  Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia.

Authors:  A Shafer; V A Doze; S L Shafer; P F White
Journal:  Anesthesiology       Date:  1988-09       Impact factor: 7.892

9.  Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion.

Authors:  J P Beller; T Pottecher; A Lugnier; P Mangin; J C Otteni
Journal:  Br J Anaesth       Date:  1988-11       Impact factor: 9.166

10.  Propofol infusion for sedation in intensive care.

Authors:  L H Newman; J C McDonald; P G Wallace; I M Ledingham
Journal:  Anaesthesia       Date:  1987-09       Impact factor: 6.955

View more
  4 in total

Review 1.  Pharmacokinetics of drugs used in critically ill adults.

Authors:  B M Power; A M Forbes; P V van Heerden; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

Review 2.  Propofol: a review of its use in intensive care sedation of adults.

Authors:  Kate McKeage; Caroline M Perry
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Inorganic fluoride concentration after long-term sedation with isoflurane.

Authors:  M A Osborne; J M Eddleston; W McNicoll
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

Review 4.  Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation.

Authors:  B Fulton; E M Sorkin
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.